

We seek to develop methods for inducing pluripotent cells such as iPSCs and embryonic stem cells toward specific cell fates, such as mesenchymal tissue (bone, etc.) cells, cardiovascular lineages, neurons, and liver and pancreatic cells. In addition, using model organisms, we conduct preclinical studies of the safety and efficacy of somatic cells differentiated from iPSCs on transplantation into various tissues in the hopes of contributing to the development of effective iPS cell therapies. The division is led by Prof. Junya Toguchida.